CLINIC-BASED BUPRENORPHINE TREATMENT: Evidence-Based for Retention in HIV Care

Details

• Corporate Authors:
  National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention
• Description:
  Clinic-based Buprenorphine Treatment integrates buprenorphine-naloxone (BUP) treatment into HIV primary care. After a 2-day BUP induction, opioid-dependent HIV clinic patients receive BUP doses in the HIV clinic 3 times weekly for 2 to 4 weeks until they are stabilized. At each clinic visit, patients also receive unstructured individual counseling, provide urine samples for point-of-care urine drug tests, take BUP doses under observation, and receive take-home supplies of BUP to last until their next clinic visit. A treatment team of the interventionist and BUP-prescribing physicians meets weekly to discuss patients’ progress in treatment.
• Subjects:
  Acquired Immunodeficiency Syndrome Acquired Immunodeficiency Syndrome / Epidemiology Data Interpretation, Statistical Epidemics Epidemiological Monitoring HIV Public Health Surveillance Statistics Tables
• Keywords:
  DHP_HIV_Reports PRS Project HIV Compendium
• Series:
  Compendium of Evidence-Based Interventions and Best Practices for HIV Prevention
• Publisher:
  Centers for Disease Control and Prevention (CDC) (U.S.)
• Document Type:
  Text
• Genre:
  Report
• Place as Subject:
  United States
• Rights:
  Public Domain
• CIO:
  National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention (NCHHSTP)
• Division:
  DHP - Division of HIV/AIDS Prevention
• Topic:
  Diseases & Conditions
• Location:
  North America
• Collection(s):
  Infectious Diseases
• Main Document Checksum:
  urn:sha-512:86afec2c8632d6109dcc64fdca4751f183d6fd7902f30db3a811a4187e133debb9f489420cf9023004e6c1aba4a4cdfb1f6fde9679f74ed0fee2869a43562b96
• Download URL:
  https://stacks.cdc.gov/view/cdc/149371/cdc_149371_DS1.pdf
• File Type:
  [PDF - 628.18 KB ]